Macrophages control the initiation and progression of NAFLD through releasing several inflammatory factors or chemokines, such as monocyte chemotactic protein 1 (MCP-1), interleukin-1β, and tumor necrosis factor α [7–10]. Here, CCL2 is linked to metabolic dysfunction-associated steatotic liver disease.